Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/1995
09/19/1995US5451590 Antiestrogen, benzothiophene derivative, preventing early sexual development
09/19/1995US5451589 Methods of inhibiting ovarian dysgenesis, delayed puberty, or sexual infantilism
09/19/1995US5451588 Imidazole, triazole and tetrazole derivatives
09/19/1995US5451587 3-(2-propynyloxy)-1-azabicyclo(2.2.2)octane for treating alzheimer*s disease
09/19/1995US5451586 Substance P antagonist
09/19/1995US5451580 Method for treating insult to neurons prone to Parkinson's degeneration employing an ATP-sensitive potassium channel blocker
09/19/1995US5451576 Tumor imaging and treatment by water soluble texaphyrin metal complexes
09/19/1995US5451573 Substituted cyclohexane derivatives for the treatment of diseases
09/19/1995US5451511 Process for the preparation of antiparasitic agents
09/19/1995US5451410 Modified amino acids for encapsulating active agents
09/19/1995US5451408 Pain management with liposome-encapsulated analgesic drugs
09/19/1995US5451405 Skin treatment composition
09/19/1995US5451402 Method for killing yeast and sporular microorganisms with haloperoxidase-containing compositions
09/19/1995US5451397 Crosslinked amino functional acrylic amide polymer, reducing blood cholesterol levels
09/19/1995US5451205 Remove and store portion of blood of patient, administer biocompatible oxygen carrier, return blood after patient has blood loss
09/19/1995CA2144940A1 Therapeutic agent for thrombocytopenia and indolocarbazole derivatives
09/19/1995CA2144810A1 Ophthalmic preparations for reducing intraocular pressure
09/19/1995CA1337074C 1,4-dihydropyridine-threonine derivatives with cardiovascular activity
09/19/1995CA1337073C 4 amino quinolines and naphthyridines, process for their preparation and their use as medicines
09/19/1995CA1337072C 5-substituted [4,5-c] imidazopyridines
09/19/1995CA1337047C Gamma inulin compositions
09/19/1995CA1337046C Thrombolytic agent
09/19/1995CA1337045C Method for inhibiting the growth of salmonella
09/17/1995CA2144385A1 Treatment of alzheimer's disease employing inhibitors of cathepsin d
09/16/1995CA2144591A1 Method for stabilizing pranoprofen and stable liquid preparation of pranoprofen
09/16/1995CA2144556A1 Alpha-pyrones compositions used for inducing and activating the growth of hair and (or) slowing down the loss of hair; use thereof
09/15/1995CA2144500A1 Pharmaceutical preparation
09/15/1995CA2144374A1 Benzimidazoles, pharmaceutical compositions containing these compounds and processes for preparing them
09/14/1995WO1995024497A2 Enzymatic preparation of polysaccharides
09/14/1995WO1995024495A1 Transgenic production of oligosaccharides and glycoconjugates
09/14/1995WO1995024489A1 Targeted cleavage of rna using ribonuclease p targeting and cleavage sequences
09/14/1995WO1995024485A2 Coordinate in vivo gene expression
09/14/1995WO1995024466A1 Transforming growth factor alpha h1
09/14/1995WO1995024437A1 Polymer-conjugated malonic acid derivatives and their use as medicaments and diagnostic agents
09/14/1995WO1995024416A1 Novel silyl compounds and their use
09/14/1995WO1995024415A1 Steroid derivatives, pharmaceutical compositions containing them, and their pharmaceutical uses
09/14/1995WO1995024414A1 Fibroblast growth factor-10
09/14/1995WO1995024408A1 Benzothiophene, benzofuran and indolethiazepinones, oxazepinones and diazepinones as inhibitors of cell adhesion and as inhibitors of hiv
09/14/1995WO1995024402A1 9-deoxotaxane compounds
09/14/1995WO1995024400A1 Thiazolidinedione derivatives as anti-hyperglycemic agents
09/14/1995WO1995024398A1 Isoxazoline compounds as inhibitors of tnf release
09/14/1995WO1995024397A1 3,5-disubstituted and 3,5,6-trisubstituted 2-isoxazolines and isoxazoles, process for preparing the same and their use as medicaments
09/14/1995WO1995024395A1 Quinoline derivatives as immunomodulators
09/14/1995WO1995024393A1 Naphthalene derivatives as prostaglandin i2 agonists
09/14/1995WO1995024391A1 Piperidines and pyrrolidines
09/14/1995WO1995024389A1 Indole derivatives as cck receptor antagonists
09/14/1995WO1995024385A1 Sulphonamide derivatives as aspartyl protease inhibitors
09/14/1995WO1995024382A1 L-n6-(1-iminoethyl)lysine derivatives useful as nitric oxide synthase inhibitors
09/14/1995WO1995024381A1 Cyano compounds and preparations thereof
09/14/1995WO1995024379A1 Benzamide analogs, useful as parp (adp-ribosyltransferase, adprt) dna repair enzyme inhibitors
09/14/1995WO1995024221A1 Bioactive and/or targeted dendrimer conjugates
09/14/1995WO1995024207A1 Composition for the treatment of lung disease
09/14/1995WO1995024204A1 Chemical castration
09/14/1995WO1995024202A1 Ribozyme therapy for restenosis
09/14/1995WO1995024200A1 Method for treating 5ht2b receptor related conditions
09/14/1995WO1995024199A2 Use of compounds which inhibit phosphatidic acid formation for the manufacture of a medicament for the treatment of cancer
09/14/1995WO1995024197A1 Percutaneously absorbable plaster comprising acid-addition salt of morphine
09/14/1995WO1995024196A1 New use of quinoline-3-carboxamide compounds
09/14/1995WO1995024195A1 New use of quinoline-3-carboxamide compounds
09/14/1995WO1995024194A1 Treatment of obsessive-compulsive disorders with 5-ht2 antagonists
09/14/1995WO1995024193A1 Topical preparations
09/14/1995WO1995024192A1 Isoxazoline compounds as 5-lipoxygenase inhibitors
09/14/1995WO1995024191A1 8-substituted tetrahydro-beta-carbolines
09/14/1995WO1995024190A2 Receptor tyrosine kinase inhibitors for inhibiting cell proliferative disorders and compositions thereof
09/14/1995WO1995024189A1 Increasing fetal hemoglobin levels using carboxylic esters
09/14/1995WO1995024188A1 Slow-release tablet containing diclofenac-na
09/14/1995WO1995024187A1 Plaster-shaped transdermal system with a tamoxifen derivative
09/14/1995WO1995024186A1 Sulfonamide derivatives and their use
09/14/1995WO1995024182A1 Human osteoclast-derived cathepsin
09/14/1995WO1995024181A1 Inhibition of hair growth
09/14/1995WO1995024172A1 Drug-containing adhesive composite transdermal delivery device
09/14/1995WO1995024168A1 In situ dissolution of alginate coatings of biological tissue transplants
09/14/1995WO1995003406A3 Enhancement of oligonucleotide inhibition of protein production, cell proliferation, and/or multiplication of infectious disease pathogens
09/14/1995DE4408326A1 Retardtablette mit einem Gehalt an Diclofenac-Na Release tablet containing diclofenac-Na
09/14/1995DE4408084A1 3,5-Disubstituierte und 3,4,5-trisubstituierte 2-Isoxazoline und Isoxazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel 3,5-Disubstituted and 3,4,5-trisubstituted 2-isoxazolines and isoxazoles, to processes for their preparation and their use as medicaments
09/14/1995DE4407995A1 Topische Zubereitungen Topical preparations
09/14/1995DE4407545A1 Use of a modified saccharide, esp. derived from bacterium or parasite
09/14/1995CA2443236A1 Human osteoclast-derived cathepsin
09/14/1995CA2350941A1 Benzamide analogues as parp dna repair enzyme inhibitors
09/14/1995CA2214521A1 Quinoline derivatives as immunomodulators
09/14/1995CA2185236A1 Method for treating 5ht2b receptor related conditions
09/14/1995CA2185235A1 8-substituted tetrahydro-beta-carbolines
09/14/1995CA2185229A1 Polymer-conjugated malonic acid derivatives and their use as medicaments and diagnostic agents
09/14/1995CA2185227A1 Percutaneous absorption applying sheet comprising acid salt of morphine
09/14/1995CA2185136A1 New use of quinoline-3-carboxamide compounds
09/14/1995CA2185135A1 New use of quinoline-3-carboxamide compounds
09/14/1995CA2185117A1 Targeted cleavage of rna using ribonuclease p targeting and cleavage sequences
09/14/1995CA2185104A1 Naphthalene derivatives as prostaglandin 12 agonists
09/14/1995CA2185016A1 Transdermal system in the form of a patch comprising a tamoxifen derivative
09/14/1995CA2185004A1 3,5-disubstituted and 3,4,5-trisubstituted 2-isoxazolines and isoxazoles, process for preparing the same and their use as medicaments
09/14/1995CA2184989A1 Ribozyme therapy for restenosis
09/14/1995CA2184739A1 Thiazolidinedione derivatives as anti-hyperglycemic agents
09/14/1995CA2184695A1 Increasing fetal hemoglobin levels using carboxylic esters
09/14/1995CA2184686A1 Transgenic production of oligosaccharides and glycoconjugates
09/14/1995CA2184583A1 Transforming growth factor alpha h1
09/14/1995CA2184385A1 Composition for the treatment of lung disease
09/14/1995CA2184114A1 Indole derivatives as cck receptor antagonists
09/14/1995CA2183961A1 Fibroblast growth factor-10
09/14/1995CA2183653A1 Sulphonamide derivatives as aspartyl protease inhibitors
09/14/1995CA2183428A1 Sulfonamide derivatives and their use
1 ... 6984 6985 6986 6987 6988 6989 6990 6991 6992 6993 6994 6995 6996 6997 6998 6999 7000 7001 7002 7003 7004 ... 7860